Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Yeremeev

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Tuberculosis (Edinburgh, Scotland)|May 4, 2015
Neutrophils exacerbate tuberculosis infection in genetically susceptible miceVladimir Yeremeev, Irina Linge, Tatiana Kondratieva, et al.
The Journal of Clinical Investigation|December 16, 2004
Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88Cecile M Fremond, Vladimir Yeremeev, Delphine M Nicolle, et al.
Vaccines|November 26, 2024
A Cap-Optimized mRNA Encoding Multiepitope Antigen ESAT6 Induces Robust Cellular and Humoral Immune Responses Against <i>Mycobacterium tuberculosis</i>Alena Kozlova, Ildus Pateev, Galina Shepelkova, et al.
Respiratory Research|November 16, 2005
Membrane TNF confers protection to acute mycobacterial infectionCecile Fremond, Nasiema Allie, Ivy Dambuza, et al.
The Journal of Experimental Medicine|March 31, 2010
The adaptor molecule CARD9 is essential for tuberculosis controlAnca Dorhoi, Christiane Desel, Vladimir Yeremeev, et al.
American Journal of Respiratory and Critical Care Medicine|October 3, 2014
Lung-residing myeloid-derived suppressors display dual functionality in murine pulmonary tuberculosisJulia K Knaul, Sabine Jörg, Dagmar Oberbeck-Mueller, et al.
Microbes and Infection|August 18, 2004
Toll-like receptor pathways in the immune responses to mycobacteriaValerie Quesniaux, Cecile Fremond, Muazzam Jacobs, et al.
Scientific Reports|May 10, 2013
Prominent role for T cell-derived tumour necrosis factor for sustained control of Mycobacterium tuberculosis infectionNasiema Allie, Sergei I Grivennikov, Roanne Keeton, et al.
European Journal of Immunology|May 1, 2014
Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamicsAnca Dorhoi, Vladimir Yeremeev, Geraldine Nouailles, et al.
International Journal of Molecular Sciences|January 23, 2024
Untranslated Region Sequences and the Efficacy of mRNA Vaccines against TuberculosisVasiliy Reshetnikov, Ilya Terenin, Galina Shepelkova, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Tuberculosis (Edinburgh, Scotland)|May 4, 2015
Neutrophils exacerbate tuberculosis infection in genetically susceptible miceVladimir Yeremeev, Irina Linge, Tatiana Kondratieva, et al.
The Journal of Clinical Investigation|December 16, 2004
Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88Cecile M Fremond, Vladimir Yeremeev, Delphine M Nicolle, et al.
Vaccines|November 26, 2024
A Cap-Optimized mRNA Encoding Multiepitope Antigen ESAT6 Induces Robust Cellular and Humoral Immune Responses Against <i>Mycobacterium tuberculosis</i>Alena Kozlova, Ildus Pateev, Galina Shepelkova, et al.
Respiratory Research|November 16, 2005
Membrane TNF confers protection to acute mycobacterial infectionCecile Fremond, Nasiema Allie, Ivy Dambuza, et al.
The Journal of Experimental Medicine|March 31, 2010
The adaptor molecule CARD9 is essential for tuberculosis controlAnca Dorhoi, Christiane Desel, Vladimir Yeremeev, et al.
American Journal of Respiratory and Critical Care Medicine|October 3, 2014
Lung-residing myeloid-derived suppressors display dual functionality in murine pulmonary tuberculosisJulia K Knaul, Sabine Jörg, Dagmar Oberbeck-Mueller, et al.
Microbes and Infection|August 18, 2004
Toll-like receptor pathways in the immune responses to mycobacteriaValerie Quesniaux, Cecile Fremond, Muazzam Jacobs, et al.
Scientific Reports|May 10, 2013
Prominent role for T cell-derived tumour necrosis factor for sustained control of Mycobacterium tuberculosis infectionNasiema Allie, Sergei I Grivennikov, Roanne Keeton, et al.
European Journal of Immunology|May 1, 2014
Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamicsAnca Dorhoi, Vladimir Yeremeev, Geraldine Nouailles, et al.
International Journal of Molecular Sciences|January 23, 2024
Untranslated Region Sequences and the Efficacy of mRNA Vaccines against TuberculosisVasiliy Reshetnikov, Ilya Terenin, Galina Shepelkova, et al.
Pageof 1